Patent details

Basic Information

Publication number:

EP1162951

PCT Application Number:

PCT/US/00/04636

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP009087800

PCT Publication Number:

WO/00/05001

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

CONTROLLED RELEASE BUPROPION FORMULATION

French Title of Invention:

FORMULATION DE BUPROPION A LIBERATION CONTROLEE

German Title of Invention:

BUPROPION-DARREICHUNGSFORM MIT KONTROLLIERTER FREISETZUNG

SPC Number:

Dates

Filing date:

24/02/2000

Grant date:

18/06/2003

EP Publication Date:

18/06/2003

PCT Publication Date:

31/08/2000

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/12/2001

EP B1 Publication Date:

18/06/2003

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

24/02/2004

Expiration date:

24/02/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

24/02/2000

 

 

Name:

ANDRX PHARMACEUTICALS INC.

Address:

Suite 201, 4001 S.W. 47th Avenue, Fort Lauderdale, FL 33314, United States (US)

Inventor

1

Name:

CHEN Chih-Ming

Address:

United States (US)

2

Name:

XIE Jianbo

Address:

United States (US)

3

Name:

JAN Steve

Address:

United States (US)

Priority

Priority Number:

259133

Priority Date:

26/02/1999

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 9/14;

Filing date	Document type	Number of pages